![Daniel P. Menard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel P.
Menard is President and Chief Operating Officer of Algos Therapeutics, Inc. He joined MDS Pharma Services in 2001 and served as Vice President and General Manager.
Dr. Menard joined AstraZeneca Montreal as a Research.
He has over 15 years of industrial and academic drug development experience.
| Sociétés | Poste | Fin |
|---|---|---|
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Corporate Officer/Principal | - |
MDS Pharma Services (Canada)
 MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services Provides contract drug discovery and drug development services | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Health Technology |
MDS Pharma Services (Canada)
MDS Pharma Services (Canada) Miscellaneous Commercial ServicesCommercial Services Provides contract drug discovery and drug development services | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
